日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

Nation
Pharma firms start work on H1N1 vaccine
2009-Jul-7 11:03:08

China has announced that it would stockpile the H1N1 flu vaccine for 1 percent of the population by Oct 1, even as the 10 designated Chinese vaccine producers are getting busy with development and clinical trials.

The stockpile of 13 million injections will be used as a preventive measure to counter any sudden outbreak of the flu, Liang Wannian, deputy director of the Ministry of Health's contingency office, said.

He said the flu vaccine would be chiefly targeted at high-risk groups -- people with prevalent illnesses and pregnant women.

The first batch of China's H1N1 flu vaccine, developed by these 10 companies, is expected to be ready by the end of the month, and would undergo a two-month clinical trial before it is made available to the public, he said.

The 10 local vaccine makers include Beijing Sinovac Biotech Co Ltd, Zhuhai Hualan Biological Engineering Inc and Shenzhen Neptunus Interlong Bio-tech Co Ltd.

Sinovac announced recently that it had completed construction of the H1N1 virus seed bank necessary to produce a virus antigen.

The company received the seed virus from the US Center for Disease Control on June 8 and started producing the H1N1 vaccine the same day.

Sinovac said it expected to complete production of the first batch and initiate clinical trials of the vaccine by the end of this month. The flu vaccine has been named PANFLU.

The company got 100 million yuan on June 29 as loan from the Bank of Beijing, which will be used to purchase pharmaceutical raw material and for expanding its manufacturing facility, according to Sinovac Chairman, President and CEO Yin Weidong. The company's current annual vaccine production capacity is between 20 million and 30 million doses.

Shenzhen-listed Hualan Biological Engineering Inc said on July 1 that its equity holding subsidiary Hualan Biological Vaccine Co Ltd, a H1N1 vaccine developer, had borrowed 20 million yuan from each of the two shareholders of the parent company to fund its vaccine development effort.

Hualan can now manufacture nearly 200 million doses annually.

Li Yingpeng, a pharmaceutical analyst at Galaxy Securities, said 13 million doses of the H1N1 vaccine implied the vaccine makers could net a business of over 300 million yuan, as the average market price of other vaccines in China was around 30 yuan per dose.

"Though it seems these 10 companies have grabbed the huge business opportunities, they are, at the same time, shouldering high risks," Li said.

He said since the evolution of the H1N1 flu could not be predicted accurately, the returns on the huge investment required for development of the vaccine and clinical trials could not be guaranteed.

[Jump to ]
Nation | Biz | Comment | World | Celebrity | Odds | Sports | Travel | Health
ChinaDaily Mobile News
m.chinadaily.com.cn
To subscribe to China Daily, call 010-64918763 or email to circu@chinadaily.com.cn
主站蜘蛛池模板: 超碰在线人 | 人人av在线 | 五月久久| 国产91高清 | 操欧美老女人 | 欧美一级特黄高清视频 | 天天草天天草 | 99爱视频在线观看 | 亚洲天堂福利 | 能看毛片的网站 | 99久久久精品免费观看国产 | 特黄视频免费看 | 欧美成人精品一区二区 | 韩国av中文字幕 | 免费在线日本 | 国产精品99久久久久 | 成人黄色a| 日韩成人区 | 四虎国产在线 | 四虎少妇做爰免费视频网站四 | 69老司机| 亚洲三级在线视频 | 三级视频在线看 | 国产免费黄 | 成年人午夜视频 | 亚洲最大成人在线 | 黄色a级片在线观看 | 天天综合永久 | 日韩欧美成 | 91网站免费看 | 日韩国产在线观看 | 懂色av一区二区三区四区 | 久久久久黄色片 | 男人午夜网站 | 亚洲成人资源 | 天干夜天干天天天爽视频 | 国产一区不卡在线 | 麻豆做爰免费观看 | 色男人的天堂 | 欧洲三级视频 | 天天操婷婷 |